Representatives from Tilray Brands met German government representatives last month to discuss the planned legalisation of adult-use cannabis in Germany – but some of the information in the New York-based company’s report of the meeting has since been contradicted by officials.
Tilray, which described the meeting as a “policy roundtable”, said the German commissioner on narcotic drugs, Burkhard Blienert, had presented the government’s plan for cannabis legalisation and reiterated that the government still intended to present a first draft of the bill in the coming months. But Bundestag (German parliament) member Carlos Kasper, who attended the Berlin meeting, told CBD-Intel that Blienert had not presented a plan for legalisation, but only “outlined the schedule that has already been published several times”.